Quotes BioVaxys Technology Corp. Deutsche Boerse AG
Equities
5LB
CA09076M1014
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0365 EUR | -.--% |
|
-.--% | +107.39% |
Performance
3 months | -24.90% | ||
6 months | +265.00% | ||
Current year | +107.39% | ||
1 year | +82.50% | ||
3 years | -75.42% |
Volumes
marketsBasic data
Highs and lows
![Extreme 0.0212](/images/extremecours_fleche.png)
![Extreme 0.0006](/images/extremecours_fleche.png)
![Extreme 0.0006](/images/extremecours_fleche.png)
![Extreme 0.0006](/images/extremecours_fleche.png)
![Extreme 0.0006](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -.--% | +107.39% | +82.50% | 11.24M | ||
-0.57% | -2.50% | +15.19% | +35.07% | 121B | ||
+0.84% | +1.60% | +19.91% | +35.06% | 114B | ||
-1.44% | -8.08% | -19.80% | -21.00% | 20.43B | ||
-0.04% | +0.28% | -16.26% | -30.57% | 16.55B | ||
+0.37% | -3.98% | -13.45% | -12.92% | 16.45B | ||
-1.46% | -7.35% | -44.35% | -36.03% | 15.59B | ||
+30.14% | +30.84% | +66.67% | +40.87% | 15.19B | ||
+0.37% | -0.65% | +2.13% | +39.61% | 13.54B | ||
+5.07% | +6.37% | +119.39% | +240.63% | 10.96B | ||
+3.00% | +2.74% | +19.33% | +38.62% | 8.15B | ||
+4.44% | +0.38% | -29.18% | -42.64% | 7.77B | ||
-0.07% | +0.28% | -1.77% | +28.71% | 7.59B | ||
+5.12% | +0.16% | +1.51% | +44.97% | 7.33B | ||
+5.41% | +25.48% | +117.71% | +206.14% | 6.85B | ||
+1.36% | +4.14% | +39.48% | +51.00% | 6.56B | ||
Average | +1.12% | +2.52% | +23.99% | +43.75% | ||
Weighted average by Cap. | +0.36% | +0.50% | +15.12% | +32.49% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +107.39% | ||
2023 | -76.78% | ||
2022 | -44.26% | ||
2021 | +3.03% | ||
2020 | -50.28% |
- Stock Market
- Equities
- BIOV Stock
- 5LB Stock
- Quotes BioVaxys Technology Corp.